Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05623319 |
| Title | Pembrolizumab and Olaparib Treatment of Extensive Small Cell Lung Cancer (ES-SCLC) (THOR) |
| Acronym | THOR |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |